Biotechnology: Diagnostics That Redirect Patient Care
While its been decades in the making, the actualization of personalized medicine may finally be here. Developers of practice-changing in-vitro diagnostic (IVDs) tests, however, still have an uphill battle convincing payers and providers of the value of their products. We can help you design and execute compelling studies using existing data sources, moving your product closer to adoption into the clinic.
Pharmaceuticals: Drugs That Heal
Decision-makers in healthcare systems who determine which new medications are accepted onto formulary are often not on the front lines caring for patients. We can help you identify unanswered clinical questions related to utility and value of your drug. Primary data collection using large multi-site clinical trial methodologies may be prohibitively expensive and time consuming; we can creatively identify and access existing data sources to demonstrate the value of your drug in real time.
State and Federal Government
As experts in technology assessment, we and our network have critically reviewed large government-funded research programs for relevance and potential utility of scientific findings discovered on the benchtop. Given our core team of experts in combination with our extended network of clinicians and researchers we are well equipped to execute customized reviews in response to government-issued RFPs.